Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes.

Leukemia·2025
Same author

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Leukemia·2025
Same author

Liver transplantation in well-selected patients with unresectable colorectal liver metastases.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same author

Are real world data real world data?

Leukemia·2025
Same author

Combined heterozygosity for the highly unstable variant hemoglobin Taybe, and α-thalassemia as a rare cause of hemolytic anemia.

Annals of hematology·2025
Same author

Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia.

Leukemia·2025

相关实验视频

Updated: Jul 13, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

慢性骨髓性白血病 慢性骨髓性白血病

Rüdiger Hehlmann1, Andreas Hochhaus, Michele Baccarani

  • 1III Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany. Ruediger.Hehlmann@med3.ma.uni-heidelberg.de

Lancet (London, England)
|July 31, 2007
PubMed
概括

慢性髓性白血病 (CML) 是一种模范性癌症,原因明确,治疗有针对性. 伊马替尼 (imatinib) 彻底改变了CML的治疗方法,其缓解率很高,并且正在研究新的治疗方法.

科学领域:

  • 在瘤学瘤学.
  • 血液学 血液学 血液学
  • 药物基因组学 药物基因组学

背景情况:

  • 慢性髓性白血病 (CML) 是一种具有已知病理生理学的瘤性疾病.
  • 它的遗传基因 (BCR-ABL融合基因) 使得开发有针对性的疗法成为可能.
  • CML 作为基因型驱动癌症治疗的范例.

研究的目的:

  • 审查当前慢性阶段CML的管理.
  • 提供关于监测CML患者疾病状况的指导.
  • 突出针对性治疗对CML结局的影响.

主要方法:

  • 关于CML病理生理学,诊断和治疗的文献综述.
  • 对治疗指南和临床试验结果的分析.
  • 讨论实现完全细胞遗传缓解的监测策略.

主要成果:

  • 伊马替尼是一种BCR-ABL氨酸激酶抑制剂,是慢性阶段CML的标准一线治疗.
  • 完全细胞遗传性缓解的高率 (高达87%) 可以在imatinib.
  • 替代疗法包括阿尔法干扰素,干细胞移植,剂量升级或治疗失败时的新药.

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

相关实验视频

Last Updated: Jul 13, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

结论:

  • 伊马替尼已经改变了CML的管理,提供了高疗效和改善患者的结果.
  • 密切监测对于评估治疗反应和管理CML至关重要.
  • 目前正在进行的研究探索新的药物和组合疗法,以进一步改善CML治疗.